Development of an intracranial mass-like lesion during growth hormone treatment in a pediatric patient with history of medulloblastoma

Pediatr Blood Cancer. 2021 Feb;68(2):e28616. doi: 10.1002/pbc.28616. Epub 2020 Aug 3.

Authors

Irmhild Altmann-Schneider¹, Boudewijn Bakker², Lisethe Meijer³, Maarten H Lequin¹

Affiliations

¹ Department of Radiology, Utrecht University Medical Center, Utrecht, The Netherlands.
² Department of Pediatric Endocrinology, Utrecht University Medical Center, Utrecht, The Netherlands.
³ Department of Neurooncology, Princess Maxima Center for Pediatric Oncology, Bilthoven, The Netherlands.

PMID: 32743847
DOI: 10.1002/pbc.28616

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
Brain Neoplasms / pathology
Brain Neoplasms / therapy*
Cerebellar Neoplasms / pathology
Cerebellar Neoplasms / therapy*
Child, Preschool
Growth Hormone / adverse effects*
Growth Hormone / therapeutic use
Humans
Intracranial Pressure / drug effects
Intracranial Pressure / physiology*
Male
Medulloblastoma / drug therapy
Medulloblastoma / pathology*
Medulloblastoma / radiotherapy

Substances

Antineoplastic Agents
Growth Hormone